Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$67,499,384
+$12,797,868 QoQ
Shares Held
265,777
+18.8% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.78%
of 13F equity value
Holder Rank
#383
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 46%
Shared 5%
None 49%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Savant Capital, LLC holds $304,795,936 across 15 Drug Manufacturers - General names. JNJ ranks #2 (22.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
67,429 | $80,876,372 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
265,777 | $67,499,384 | |
| 3 | ABBV |
AbbVie Inc.
|
205,994 | $51,836,330 | |
| 4 | MRK |
Merck & Co., Inc.
|
220,270 | $28,304,695 | |
| 5 | NVS |
Novartis AG
|
150,968 | $23,659,704 | |
| 6 | AMGN |
Amgen Inc
|
40,234 | $14,569,536 | |
| 7 | PFE |
Pfizer Inc
|
423,589 | $10,200,023 | |
| 8 | AZN |
Astrazeneca PLC
|
35,321 | $6,697,568 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $67,499,384 | 265,777 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $54,701,516 | 223,783 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $42,475,452 | 205,245 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $38,514,886 | 207,717 | Shares | Sole | 2026-03-04 | |
| 2025-06-30 | $31,030,246 | 203,144 | Shares | Sole | 2026-03-04 | |
| 2025-03-31 | $32,899,670 | 198,382 | Shares | Sole | 2026-03-04 | |
| 2024-12-31 | $35,902,782 | 248,256 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $40,114,225 | 247,527 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $33,822,447 | 231,407 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $35,406,876 | 223,825 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $34,052,235 | 217,253 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $35,161,029 | 225,753 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $41,563,065 | 251,106 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $29,939,180 | 193,156 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $30,588,714 | 173,160 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,840,863 | 41,876 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $7,507,075 | 42,291 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $6,693,090 | 37,765 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $6,343,446 | 37,081 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $5,885,383 | 36,442 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,911,365 | 35,883 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $5,986,777 | 36,427 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $5,573,297 | 35,413 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $5,518,683 | 37,068 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $5,207,528 | 37,030 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $4,517,428 | 34,450 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||